![](/img/cover-not-exists.png)
Is combining PARP and androgen receptor inhibition really a winning strategy in metastatic castration-resistant prostate cancer?
Di Nunno, Vincenzo, Santoni, Matteo, Massari, FrancescoVolume:
19
Language:
english
Journal:
The Lancet Oncology
DOI:
10.1016/S1470-2045(18)30458-3
Date:
September, 2018
File:
PDF, 59 KB
english, 2018